







The latest Omron clip-on oximeter
Omron is a world-renowned manufacturer of automatic control and electronic equipment, focusing on industrial automation, control devices, robots and medical equipment. It is committed to providing efficient and reliable solutions to global customers and has won the trust of global users with its excellent quality and innovative spirit.
Data from the World Health Organization's 2022 report shows that cardiovascular disease, rather than cancer, is the most common disease today, and it is becoming younger. In response to this event, the company launched a medical blood glucose meter to prevent and treat cardiovascular diseases such as hypertension/hyperlipidemia and to control blood sugar levels in diabetic patients. We have a complete hearing aid production chain and our products are sold all over the world.
In order to end 2024 perfectly and welcome 2025 smoothly, we have signed a promotion agreement with a local trader in Hungary, that is, the price of all products will be reduced by 50%, that is, the new model of Omron non-invasive blood glucose meter
There's only one day left, and there are only 270 pieces left, while stocks last.
This medical blood glucose meter complies with European CE certification, US FDA certification and CFDA certification
Sensor accurate measurement value
The most painful part of diabetes treatment is measuring blood sugar levels from the fingertip. So far, all attempts to avoid puncture (e.g., measuring tissue glucose in the infrared range) have failed. Now it seems that this problem has been solved, and a collaboration between Italy and Japan may make it possible to measure blood sugar without a fingertip, which is considered the "holy grail" of diabetes treatment.
Professor Stefano Valenzi worked closely with Japanese researchers to create the GlucoScanner, which does not require finger pricking, using new technology and they are developing a commercial version.
It seems that they have successfully solved the optical problems caused by differences in skin pigmentation. The device must be calibrated individually, for example by touching with the left thumb, and then the same finger can be used to measure blood sugar levels at any time.
After countless tests and thousands of measurements, a high level of accuracy has been achieved, approaching or even reaching the accuracy of traditional blood glucose meters.
GlucoScanner is a novel non-invasive blood glucose biosensor that uses optical technology and signal processing technology. The project is currently in the final stages of development at Dynamic Brain Lab, LLC in Tokyo.
Don't choose
There are many competitors in the market selling blood glucose monitoring devices.
In reality, they sell invasive devices that are extremely annoying and painful.
Through cloud-based software and a mobile app, the device can send alerts to caregivers and selected relatives or friends in the event of an emergency. All the data needed to monitor general health can be collected. Developed by Stefano Valenzi and Peter Jurica, the system aims to increase data accessibility and ultimately facilitate communication between patients, scientists and healthcare professionals.
Using non-standard light frequencies in the infrared spectrum. The Dynamic Brain Lab has developed a new method to evaluate tissue light absorption data. The device combines light absorption information with other physiological data and personal physical characteristics. This allowed the research team to address some well-known issues associated with optical technologies, such as differences in skin pigmentation. A simple automatic calibration procedure performed on the patient's finger guides the user to adjust the GlucoScanner to optimize device performance.
Regularly measuring blood sugar levels can help prevent complications.
Controlling blood sugar levels is an important part of diabetes self-management. Fortunately, Hungarian patients now have access to home blood sugar monitoring devices, including high-quality Hungarian devices and devices manufactured in other parts of the EU. Blood sugar control is important for people with diabetes for many reasons.
Are there proven benefits to regular measurement?
Yes, some international studies have demonstrated the usefulness of self-examination in large numbers of patients. In the so-called ROSSO study, patients treated with insulin and/or medication or diet were observed for an average of 6.5 years. Almost 3,300 participants were divided into two groups: one that regularly tested their blood sugar, and the other that did not. They were curious about how the number of deaths and serious complications related to diabetes (heart attacks, strokes, blindness, kidney failure, leg problems) occurred in the two groups.
The two figures attached speak for themselves: in the self-monitoring group, non-fatal complications fell by 32% and mortality fell by 52%. They investigated separately whether the good effects could be observed with tablets or dietary treatment, and the results were also positive.



